ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 24 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,503 | -20.5% | 82,926 | -28.6% | 0.00% | -100.0% |
| Q2 2023 | $1,194,279 | +17.3% | 116,175 | +21.0% | 0.00% | 0.0% |
| Q1 2021 | $1,018,000 | +76.4% | 96,017 | +109.8% | 0.00% | – |
| Q4 2020 | $577,000 | +42.5% | 45,771 | -0.6% | 0.00% | – |
| Q3 2020 | $405,000 | +495.6% | 46,058 | +330.7% | 0.00% | – |
| Q3 2018 | $68,000 | -38.2% | 10,694 | -22.0% | 0.00% | – |
| Q1 2018 | $110,000 | -46.3% | 13,705 | -25.0% | 0.00% | – |
| Q4 2017 | $205,000 | – | 18,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,284,900 | $11,294,000 | 3.06% |
| FRAZIER MANAGEMENT LLC | 2,571,450 | $22,603,000 | 2.03% |
| Samsara BioCapital, LLC | 494,190 | $4,344,000 | 1.21% |
| EcoR1 Capital, LLC | 741,290 | $6,516,000 | 0.46% |
| DAFNA Capital Management LLC | 148,260 | $1,303,000 | 0.42% |
| Orbimed Advisors | 3,670,955 | $32,268,000 | 0.41% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,211,000 | 0.34% |
| Avidity Partners Management LP | 810,000 | $7,120,000 | 0.33% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $1,743,000 | 0.17% |
| Artal Group S.A. | 593,030 | $5,213,000 | 0.13% |